Lawrenceville, NJ, United States of America

Jay Edward Wrobel

This inventor holds 96 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D-). Top assignees: Wyeth, American Home Products Corporation, Biohaven Therapeutics Ltd.. Active years: 1989-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jay Edward Wrobel. Retrieved from https://idiyas.com/inventor/jay-edward-wrobel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 96 (Patent Applications = 13)

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 5.0

ph-index = 25

Forward Citations = 1,516(Granted Patents)

Forward Citations (Not Self Cited) = 955(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Lawrence, NJ (US) (2009)
Lawrenceville, NJ (US) (1989 - 2024)

Company Filing History:

American Home Products Corporation

patents

11 out of 33

Biohaven Therapeutics Ltd.

patents

4. 5 out of 8

Biohaven Pharmaceutical Holding Company Limited

patents

5. 4 out of 140

Ligand Pharmaceuticals, Inc.

patents

6. 4 out of 1,499

Rutgers, The State University of New Jersey

University of Pennsylvania

patents

9. 32 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2025

Loading Chart...

Areas of Expertise:

Riluzole Prodrugs

Progesterone Receptor Modulators

Antiviral Compounds

Cyanopyrroles

Indoline Derivatives

Thio-Oxindole Derivatives

Acyl Benzo[d]thiazol-2-Amine

Cinnoline Compounds

Gonadotropin Releasing Hormone Antagonists

Quinolines

Cyclothiocarbamate Derivatives

7-Aryl 1,5-Dihydro-4,1-Benzoxazepin-2(3H)-One

96 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12472165 - Riluzole prodrugs and their use (2025-11-18),

2. 12295942 - Riluzole prodrugs and their use (2025-05-13),

3. 12213965 - Riluzole prodrugs and their use (2025-02-04),

4. 12172974 - Prodrugs of riluzole and their method of use (2024-12-24),

5. 12029731 - Acyl benzo[d]thiazol-2-amine and their methods of use (2024-07-09),

6. 12005047 - Riluzole prodrugs and their use (2024-06-11),

7. 12005046 - Riluzole prodrugs and their use (2024-06-11),

8. 11911369 - Prodrugs of riluzole and their method of use (2024-02-27),

9. 11440893 - Prodrugs of riluzole and their method of use (2022-09-13),

10. 11052070 - Riluzole prodrugs and their use (2021-07-06),

11. 10905681 - Riluzole prodrugs and their use (2021-02-02),

12. 10844026 - Prodrugs of riluzole and their method of use (2020-11-24),

13. 10639298 - Prodrugs of riluzole and their method of use (2020-05-05),

14. 10562870 - Prodrugs of riluzole and their method of use (2020-02-18),

15. 10485791 - Riluzole prodrugs and their use (2019-11-26),

Title: Spotlight on Inventor Jay Edward Wrobel

Introduction:

Inventor Jay Edward Wrobel, hailing from Lawrenceville, NJ, is a highly accomplished individual with an impressive portfolio of 92 patents to his name. His innovative spirit and dedication to advancing the field of pharmaceuticals have led to groundbreaking discoveries that have the potential to revolutionize the treatment of various diseases.

Latest Patents:

Among Jay Edward Wrobel's latest patents is the development of Acyl benzo[d]thiazol-2-amine compounds, which show promise in addressing a wide range of diseases, including neurological disorders such as amyotrophic lateral sclerosis, bipolar disorder, and various cancers like melanoma and breast cancer. Additionally, his work on Riluzole prodrugs highlights his focus on enhancing drug stability and delivery for the treatment of cancer types such as melanoma, breast cancer, and prostate cancer.

Career Highlights:

Throughout his career, Jay Edward Wrobel has made significant contributions to the field of pharmaceuticals while working with reputable companies such as Wyeth. His dedication to innovation and research has not only resulted in numerous patents but has also paved the way for advancements in drug development and treatment methodologies.

Collaborations:

Jay Edward Wrobel has collaborated with esteemed professionals in the field, including coworkers Lin Zhi and Todd Kevin Jones. These collaborations have fostered a culture of creativity and knowledge-sharing, leading to the successful development of cutting-edge pharmaceutical solutions.

Conclusion:

Inventor Jay Edward Wrobel's commitment to innovation and his remarkable track record of patent achievements underscore his invaluable contributions to the pharmaceutical industry. His relentless pursuit of groundbreaking discoveries continues to inspire future generations of inventors and researchers in the quest for improved healthcare solutions.

Profile summary based on public USPTO records.